日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data

利用真实世界数据和NATALEE数据，基于机器学习预测HR+/HER2-早期乳腺癌远处复发风险和瑞博西尼治疗效果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1946
Howard, Frederick M; Fasching, Peter A; Santa-Maria, Cesar A; Lim, Elgene; Sparano, Joseph A; Lustberg, Maryam B; Bachelot, Thomas; Blyuss, Oleg; Brezden-Masley, Christine; Park, Yeon Hee; Akdere, Murat; Ye, Fen; Pantoja, Kristyn; Kurz, Christoph; Dominguez Castro, Patricia; Razavi, Pedram
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)

加拿大乳腺癌诊疗指南：HER2+乳腺癌早期和转移期患者系统治疗的国家共识建议（2025年更新）

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33040200
Kumar, Aalok; Jerzak, Katarzyna J; Gelmon, Karen A; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Joy, Anil Abraham; Laing, Kara; LeVasseur, Nathalie; Sehdev, Sandeep; Simmons, Christine; Webster, Marc; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada
肿瘤
乳腺癌
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025

加拿大乳腺癌诊疗指南：2025年HR+/HER2-转移性乳腺癌患者系统治疗国家共识建议

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33020106
Jerzak, Katarzyna J; Kumar, Aalok; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Joy, Anil Abraham; Laing, Kara; LeVasseur, Nathalie; Lupichuk, Sasha; Sehdev, Sandeep; Simmons, Christine; Webster, Marc; Gelmon, Karen A; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025

加拿大乳腺癌诊疗指南：2025年HR+/HER2-早期乳腺癌患者系统治疗国家共识建议

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33020112
Sehdev, Sandeep; Joy, Anil Abraham; Boileau, Jean-François; Bouganim, Nathaniel; Brezden-Masley, Christine; Cao, Jeffrey Q; Cescon, David W; Chia, Stephen; Edwards, Scott; Gelmon, Karen A; Jerzak, Katarzyna J; Kumar, Aalok; Laing, Kara; LeVasseur, Nathalie; Simmons, Christine; Webster, Marc; Manna, Mita; On Behalf Of Patient Advocacy Breast Cancer Canada
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Clinician's guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer

临床医生指南：专家对早期乳腺癌患者使用 CDK4/6 抑制剂的见解

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251326710
Hussain, Marya; Brezden-Masley, Christine; Chia, Stephen; Curigliano, Giuseppe; Webster, Marc; Henning, Jan-Willem
CDK4
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Changes in female cancer diagnostic billing rates over the COVID-19 period in the Ontario Health Insurance Plan

安大略省医疗保险计划中女性癌症诊断收费标准在新冠疫情期间的变化

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251339919
McLeod, Deanna; Martins, Ilidio; Tinker, Anna V; Selk, Amanda; Brezden-Masley, Christine; LeVasseur, Nathalie; Altman, Alon D
微生物学
新冠
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada

加拿大针对HR阳性、HER2阴性早期乳腺癌患者实施辅助CDK4/6抑制剂治疗的多学科实用指南

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32080444
Jerzak, Katarzyna J; Sehdev, Sandeep; Boileau, Jean-François; Brezden-Masley, Christine; Califaretti, Nadia; Edwards, Scott; Gordon, Jenn; Henning, Jan-Willem; LeVasseur, Nathalie; Railton, Cindy
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

The Canadian Breast Cancer Symposium 2025: Meeting Report

2025年加拿大乳腺癌研讨会：会议报告

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33010015
Brezden-Masley, Christine; Jerzak, Katarzyna J; Nixon, Nancy A; Koch, Anne; Roberts, Amanda; Boileau, Jean-François; Quan, May Lynn; DeCoteau, M J; Cil, Tulin D
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Prioritizing the Timely Detection and Diagnosis of Early-Age Onset Cancer to Enable Optimal Disease Management and Outcomes

优先及时发现和诊断早期癌症，以实现最佳疾病管理和治疗效果

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32070396
Raphael, Michael J; Wildgoose, Petra; Brenner, Darren; Brezden-Masley, Christine; Burkes, Ronald; Grant, Robert C; Pettit, Alexandra; Macaulay, Cassandra; D'Angelo, Monika Slovinec; Servidio-Italiano, Filomena
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Canadian real-world hybrid longitudinal cohort study of treatment discontinuations and modifications for patients with HER2+ and HER2-low metastatic breast cancer on trastuzumab deruxtecan enrolled in a patient support programme: the HER-TEMPO study protocol

加拿大一项真实世界混合纵向队列研究，旨在探讨接受曲妥珠单抗德鲁替康治疗的HER2阳性和HER2低表达转移性乳腺癌患者在患者支持计划中的治疗中断和调整情况：HER-TEMPO研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-100889
Brezden-Masley, Christine; Qadeer, Rana; Senhaji Mouhri, Zhor; Salvo, Bianca; Bonar, Nicolle; Spin, Paul; Shokar, Simran
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏